Gainers &
Losers
Most Active &
More
52-Week
High/Low
P/E
Ratios
Large Caps
Absolute
Total Market PE
Stocks
Performance
Large Caps
Absolute
Industries
Performance
Industry
Sector
Dividends
Calendar
Earnings Calendar
Dividends Calendar
Economics Calendar
More
Investment Compounding Calculator
Commodities
Currencies
Economic Indicators
Inflation
Consumer Sentiment
Recession Probability
Treasury Rates
GDP
RVMD
$
(
%)
Exchange:
Market Cap:
Shares Outstanding:
Overview
Earnings
Financials
Valuation
Chart
About The Company
Sector:
Industry:
CEO:
Full Time Employees:
Address:
Website:
Click to read more…
Revenue Segmentation
🔒 You are currently logged out
Login
It’s free
EPS
🔒 You are currently logged out
Login
It’s free
View full analyst estimates
Earnings Call
🔒 You are currently logged out
Login
It’s free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates
Income Statement
?
(* All numbers are in thousands)
🔒 You are currently logged out
Login
It’s free
Balance Sheet
?
(* All numbers are in thousands)
🔒 You are currently logged out
Login
It’s free
Cash Flow Statement
?
(* All numbers are in thousands)
🔒 You are currently logged out
Login
It’s free
Analyst Estimates
(* All numbers are in thousands)
🔒 You are currently logged out
Login
It’s free
Current Key Metrics
?
🔒 You are currently logged out
Login
It’s free
Forward P/E Ratios
🔒 You are currently logged out
Login
It’s free
SWOT Analysis
🔒 You are currently logged out
Login
It’s free
At what price to buy it? –
Intrinsic Value Calculator
Calculate RVMD Intrinsic Value
🔒 You are currently logged out
Login
It’s free
See in
Relevant news
05-11-2025 20:41
Revolution Medicines, Inc. (RVMD) Q3 2025 Earnings Call Transcript
22-10-2025 12:12
Revolution Medicines to Present Updated Elironrasib Safety and Efficacy Data in Patients with KRAS G12C Non-Small Cell Lung Cancer Following Treatment with a KRAS(OFF) G12C Inhibitor
16-10-2025 20:00
Revolution Medicines Awarded Voucher for Daraxonrasib (RMC-6236) Under FDA Commissioner’s National Priority Voucher Pilot Program
29-09-2025 09:00
Revolution Medicines Announces Key Leadership Additions, including Alan Sandler, M.D. as Chief Development Officer
11-09-2025 13:30
Revolution Medicines: Shares Soar On Pancreatic Cancer Study Win – I’m Sold
07-08-2025 05:49
Revolution Medicines, Inc. (RVMD) Q2 2025 Earnings Call Transcript
Gainers & Losers
Most Active & More
52-Week High/Low
Dividends
P/E Ratios
Large Caps
Absolute
Total Market PE
Stocks Performance
Large Caps
Absolute
Industries Performance
Industry
Sector
Calendar
Earnings Calendar
Dividends Calendar
Economics Calendar
More
Investment Compounding Calculator
Commodities
Currencies
Economic Indicators
Inflation
Consumer Sentiment
Recession Probability
Treasury Rates
GDP
Login
Profile
Watchlists
My Valuations
Settings
Media
Watch
Listen
Read